3/10
07:07 am
dsgn
Design Therapeutics Highlights Progress Across Lead GeneTAC® Programs and Reports Fourth Quarter and Full Year 2024 Financial Results
High
Report
Design Therapeutics Highlights Progress Across Lead GeneTAC® Programs and Reports Fourth Quarter and Full Year 2024 Financial Results
3/3
08:00 am
dsgn
Design Therapeutics to Participate in Leerink’s Global Healthcare Conference
Low
Report
Design Therapeutics to Participate in Leerink’s Global Healthcare Conference